In the first study, elevated serum omentin concentrations in patients with MASLD were observed [25], which did not match past views considering low omentin levels in conditions linked to obesity and T2DM. This evidence concerns the gene ITLN1 and obesity due to melanocortin 4 receptor deficiency.